CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- Open-market buys, last 90 days
- $1,001,990
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,001,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-15 | Hutton Scott President & CEO | Option exercise · Restricted Stock Units | −2,633 | 5,265 | ||
| 2026-01-15 | Cowie Robin Harper CFO, Sec'y & Treasurer | Option exercise | +805 | 13,952 | ||
| 2026-01-15 | Cowie Robin Harper CFO, Sec'y & Treasurer | Option exercise · Restricted Stock Units | −805 | 1,609 | ||
| 2026-01-05 | PATIENCE JOHN Director | Option exercise | +1,143 | 22,661 | ||
| 2026-01-05 | PATIENCE JOHN Director | Option exercise · Restricted Stock Units | −1,143 | 0 | ||
| 2026-01-02 | Franchi Jean M. Director | Grant or award · Restricted Stock Units | +8,164 | 8,164 | ||
| 2026-01-02 | Franchi Jean M. Director | Grant or award · Stock Options (Right to Buy) | +6,354 | 6,354 | ||
| 2026-01-02 | Strobeck Matthew Director | Grant or award · Restricted Stock Units | +6,804 | 6,804 | ||
| 2026-01-02 | Strobeck Matthew Director | Grant or award · Stock Options (Right to Buy) | +6,354 | 6,354 | ||
| 2026-01-02 | PATIENCE JOHN Director | Grant or award · Restricted Stock Units | +5,443 | 5,443 | ||
| 2026-01-02 | PATIENCE JOHN Director | Grant or award · Stock Options (Right to Buy) | +6,354 | 6,354 | ||
| 2026-01-02 | MASSARANY HANY Director | Grant or award · Restricted Stock Units | +7,484 | 7,484 | ||
| 2026-01-02 | MASSARANY HANY Director | Grant or award · Stock Options (Right to Buy) | +6,354 | 6,354 | ||
| 2026-01-02 | Kennedy Lawrence T. Jr Director | Grant or award · Restricted Stock Units | +5,443 | 5,443 | ||
| 2026-01-02 | Kennedy Lawrence T. Jr Director | Grant or award · Stock Options (Right to Buy) | +6,354 | 6,354 | ||
| 2026-01-02 | Kayyem Jon Faiz Director | Grant or award · Restricted Stock Units | +5,443 | 5,443 | ||
| 2026-01-02 | Kayyem Jon Faiz Director | Grant or award · Stock Options (Right to Buy) | +6,354 | 6,354 | ||
| 2026-01-02 | Pestano Gary Anthony Chief Development Officer | Grant or award · Stock Options (Right to Buy) | +26,000 | 26,000 | ||
| 2026-01-02 | O'Kane Kieran Chief Commercial Officer | Grant or award · Stock Options (Right to Buy) | +27,000 | 27,000 | ||
| 2026-01-02 | Hutton Scott President & CEO | Grant or award · Stock Options (Right to Buy) | +97,000 | 97,000 |
Page 4 of 14 · 274 trades